John Doyle Email

Chief Financial Officer . Cognition Therapeutics

Pittsburgh, PA

Location

j*****@cogrx.com

Primary Email

Current Roles

Employees:
45
Revenue:
$3.5M
About
Cognition Therapeutics, Inc. is focused on the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer\'s disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large class of disease targets, and there are currently no therapeutics available to prevent toxic protein accumulation or block their destructive effects. Cognition is founded on the unique combination of biological expertise around these targets, including proprietary assays that emphasize functional responses and proprietary medicinal chemistry that insures novel, high quality small-molecule drug candidates.
Cognition Therapeutics Address
2500 Westchester Ave
Pittsburgh, PA
United States
Cognition Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.